Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
PROVECTUS BIOPHARMACEUTICALS, INC. See All Filings	D	2024-07-17 16:07:10 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers N/A CIK Number 0000315545 Filed Document 0001493152-24-028163 Exclusions or Exemptions 506b Accepted Date 2024-07-17 16:07:10 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TENNESSEE Revenue or Assets $$1 - $1,000,000 Type of Security Debt
PROVECTUS BIOPHARMACEUTICALS, INC. See All Filings	D	2022-10-28 13:29:32 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0000315545 Filed Document 0001493152-22-029808 Exclusions or Exemptions 506b Accepted Date 2022-10-28 13:29:32 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TENNESSEE Revenue or Assets $$1 - $1,000,000 Type of Security Debt
PROVECTUS BIOPHARMACEUTICALS, INC. See All Filings	D	2021-08-30 16:02:44 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0000315545 Filed Document 0000315545-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-08-30 16:02:44 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TENNESSEE Revenue or Assets $No Revenues Type of Security Debt
PROVECTUS BIOPHARMACEUTICALS, INC. See All Filings	D	2014-10-14 00:00:00 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers Network 1 Financial Securities, Inc. CIK Number 0000315545 Filed Document 0000315545-14-000003 Exclusions or Exemptions 506b Accepted Date 2014-10-14 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TENNESSEE Revenue or Assets Decline to Disclose Type of Security Equity
PROVECTUS BIOPHARMACEUTICALS, INC. See All Filings	D	2014-04-17 00:00:00 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers Network 1 Financial Securities, Inc. CIK Number 0000315545 Filed Document 0000315545-14-000002 Exclusions or Exemptions 506b Accepted Date 2014-04-17 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TENNESSEE Revenue or Assets Decline to Disclose Type of Security Equity
PROVECTUS PHARMACEUTICALS INC See All Filings	D	2013-09-26 00:00:00 UTC
Amount To Be Raised $16,000,000 Associated Brokers / Dealers Network 1 Financial Securities, Inc. and Maxim Group LLC CIK Number 0000315545 Filed Document 0001140361-13-037057 Exclusions or Exemptions 506b Accepted Date 2013-09-26 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TENNESSEE Revenue or Assets $No Revenues Type of Security Equity